Seppo Mäkinen, previously a ValiRx Non-Executive Director, has more than 30 years of senior advisory and executive experience in board level strategic leadership and venture capital management on life science. His career includes ten years as director in Life Sciences at Sitra (Finnish Government Fund), followed by 13 years as co-founder and Managing Partner in Bio Fund Management Oy. In 2010, Seppo founded Taikon Advisor Oy, a Finnish management consultancy firm focusing on advising and investing in life sciences ventures. He stepped down from the ValiRx Board in May 2017.
Dr Ajay Agrawal
He is an experienced entrepreneur in the biotech and pharma industry, who currently sits on the boards of companies in the UK, Europe and USA, assisting them in shaping their aims, values, and strategic goals. He also sits on the editorial board of six peer-reviewed international scientific journals from Bentham Press, California, USA, and he is the Managing Director Europe and Advisory Board Member of Ignite Capital Partners, USA and a trustee of the Ramphal Institute, London. Previously, Ajay was a founder of polyMASC Pharmaceuticals plc, London, the first UK biotech company from a university (Royal Free Hospital School of Medicine, University of London) that was directly listed on the London Stock Exchange, raising approximately $40 million in 1995, before its subsequent merger with the NASDAQ-listed company, Valentis Inc in 1999. He was a Board Director and member of the remuneration & audit committees of Immupharma plc, the AIM-listed pharmaceutical development company for over eight years.
Andrew King has almost twenty years’ experience working in the biotech and life-science sectors. He served for nearly ten years as Finance Director of the extremely successful AIM listed biotech company, NeuTec Pharma Limited, leading the business through its IPO to its subsequent sale in 2006 to Novartis Pharma AG for £305 million. He has experience across a range of sectors and has served as Finance Director and company secretary to a number of organisations including Hutchison Whampoa (Europe) Limited, Utility Cable plc and Umbro.com Limited. Most recently he served for five years as CFO to Smart Matrix Limited, a start-up medtech business spun out of a medical research charity. Since 2016 he has acted as an Associate Partner with St. James’s Place Wealth Management plc. He is a qualified Chartered Accountant (Price Waterhouse) and has a degree in law.